<DOC>
	<DOCNO>NCT01455441</DOCNO>
	<brief_summary>The objective study investigate effect physical training patient type 2 diabetes treatment GLP-1 receptor agonist liraglutide ( Victoza® ) 16-weeks double-blinded , randomized placebo-controlled clinical trial . Hypothesis : Physical training lead good metabolic control type 2 diabetic patient train combine liraglutide ( Victoza® ) treatment .</brief_summary>
	<brief_title>The Effects Physical Training GLP-1 Receptor Agonist Liraglutide Treatment Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Informed oral write consent Diagnosed type 2 diabetes accord criterion WHO HbA1C : 711 % ( treatment diet and/or metformin ) Age &gt; 18 year BMI &gt; 25 kg/m2 &lt; 40 kg/m2 Negative islet cell antibody ( ICA ) glutamate decarboxylase 65 ( GAD 65 ) autoantibody Females child bear potential pregnant , breastfeed intention become pregnant use adequate contraceptive measure . Subjects treat sulfonylurea , dipeptidyl peptidase 4 ( DPP4 ) inhibitor , insulin glitazones Ongoing abuse alcohol narcotic Impaired hepatic function ( liver transaminase &gt; 2 time upper normal limit ) Impaired renal function ( secreatinine &gt; 150μM and/or albuminuria ) Cardiac problem define decompensated heart failure ( NYHA class III IV ) , unstable angina pectoris and/or myocardial infarction within last 12 month Uncontrolled hypertension ( systolic blood pressure &gt; 180 mmHg , diastolic blood pressure &gt; 100 mmHg ) Anaemia Any condition investigator feel would interfere trial participation Receiving investigational drug within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>GLP-1</keyword>
	<keyword>Training</keyword>
	<keyword>Exercise</keyword>
	<keyword>Type 2 Diabetes</keyword>
</DOC>